Evidence map›Paper›PMID 30276622›Full record

ArticleAnnals of nuclear medicine2019

Count-based method for specific binding ratio calculation in [I-123]FP-CIT SPECT analysis.

Mahmudur G M Rahman, Muhammad M Islam, Tetsuya Tsujikawa, Yasushi Kiyono, Hidehiko Okazawa

Abstract read
In one paragraph

Article in Annals of nuclear medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. The effects of use of medications on striatal dopamine transporter binding assessed by [European journal of nuclear medicine and molecular imaging · 2026
    Article
  3. Article
  4. Specific Binding Ratio Estimation of [Diagnostics (Basel, Switzerland) · 2023
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mahmudur G M RahmanBiomedical Imaging Research Center, University of Fukui, 23-3, Matsuoka-Shimaizuki, Eiheiji, Fukui, 910-1193, Japan.
Muhammad M IslamBiomedical Imaging Research Center, University of Fukui, 23-3, Matsuoka-Shimaizuki, Eiheiji, Fukui, 910-1193, Japan.
Tetsuya TsujikawaBiomedical Imaging Research Center, University of Fukui, 23-3, Matsuoka-Shimaizuki, Eiheiji, Fukui, 910-1193, Japan.
Yasushi KiyonoBiomedical Imaging Research Center, University of Fukui, 23-3, Matsuoka-Shimaizuki, Eiheiji, Fukui, 910-1193, Japan.
Hidehiko OkazawaBiomedical Imaging Research Center, University of Fukui, 23-3, Matsuoka-Shimaizuki, Eiheiji, Fukui, 910-1193, Japan. okazawa@u-fukui.ac.jp.ORCID http://orcid.org/0000-0001-7046-3383

Funding

Japan Society for the Promotion of Science 18H02763
6 · The paper itself

Abstract

objectiveTo calculate the specific binding ratio (SBR) appropriately in dopamine transporter (DAT) imaging, a method for extracting the striatal volume of interest (VOI) was developed.

methodsThis study included 200 patients (72 ± 10 years) who were suspected of parkinsonian syndromes (PS) or dementia with Lewy body (DLB). The patients were divided into three groups of PS with dopaminergic degeneration, DLB and non-PS after [

resultsThe mean SBR values for the PS and DLB groups were significantly different from that of the non-PS group with both methods. The coefficients of variation of the SBR were significantly smaller with the proposed method compared with those of SBR

conclusionOur new method for SBR calculation in the FP-CIT SPECT showed less coefficients of variation with high reproducibility, which would be useful for clinical diagnosis and in assessing the severity of diseases in follow-up studies.

Indexed as

Tomography, Emission-Computed, Single-PhotonAgedDopamine Plasma Membrane Transport ProteinsFemaleHumansImage Processing, Computer-AssistedLewy Body DiseaseMaleNeostriatumObserver VariationParkinsonian DisordersProtein BindingROC CurveTropanes2-carbomethoxy-8-(3-fluoropropyl)-3-(4-iodophenyl)tropaneDopamine Plasma Membrane Transport ProteinsTropanesACSCCTACDAT[I-123]ioflupane (FP-CIT) SPECTSBR

Identifiers

PMID30276622
PMCPMC6314989

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.